Nortech Systems Inc: Form 10-Q for the period ended Mar 31, 2011
Filed with the SEC on May 13, 2011 and accepted by EDGAR at May 13, 2011, 09:17 ET.
Management's discussion and analysis
As filed, 12,493 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview:
We are a Wayzata, Minnesota based full-service Electronics Manufacturing Services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added services and technical support including design, testing, prototyping and supply chain management to customers mainly in the Aerospace and Defense, Medical, and Industrial Equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Fairmont, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.
Summary of Results:
For the quarter ended March 31, 2011, we reported net sales of $29.0 million compared to $21.7 million reported in the same quarter of 2010, a 33% improvement, with the recent acquisitions accounting for $5.5 million of the increase. Our 90-day backlog increased to $20.0 million as of March 31, 2011 compared to $19.0 million for the same period last year and $18.5 million at the start of the quarter.
Our gross margin in the first quarter of 2011 was 11.0% compared to 12.1% in the first quarter of 2010. The margin percentage decrease is mainly attributed to the reinstatement of wages, incentives and benefits that had been suspended in the first six months of 2010, and absorbing the cost of integrating our acquisitions.
Income from operations totaled $0.3 million for the first quarter of 2011 and 2010.
Net income for the first quarter of 2011 totaled $0.6 million or $0.23 per diluted common share, $0.1 million or $0.04 per diluted common share excluding the bargain purchase gain of $0.5 million, net of tax, compared to net income of $0.1 million, or $0.03 per diluted common share for the first quarter of 2010.
Cash used in operating activities for the three months ended March 31, 2011 was $3.9 million compared to cash provided by operating activities of $0.6 million for the same period in 2010. The revenue growth and related working capital increases in both accounts receivable and inventories account for the majority of the usage.
(1.) Results of Operations:
The following table presents statements of income data as percentages of total net sales for the periods indicated:
| Three Months Ended March 31 2011 | 2010 | |
|---|---|---|
| Net Sales | 100.0% | 100.0% |
| Cost of Goods Sold | 89.0 | 87.9 |
| Gross Profit | 11.0 | 12.1 |
| Selling Expenses | 3.2 | 3.5 |
| General and Administrative Expenses | 6.8 | 7.1 |
| Income from Operations | 1.0 | 1.5 |
| Bargain Purchase Gain | 2.7 | 0.0 |
| Other Income (Expenses), Net | (0.5) | (0.8) |
| Income Before Income Taxes | 3.2 | 0.7 |
| Income Tax Expense | 1.0 | 0.3 |
| Net Income | 2.2% | 0.4% |
Net Sales:
We reported net sales of $29.0 million and $21.7 million for the three months ended March 31, 2011 and 2010, respectively. The 2011 net sales were impacted by our two new acquisitions; the Milaca medical device operation acquired in May 2010 accounted for $1.5 million and the Mankato operation acquired in January 2011 accounted for $4.0 million of net sales for the three months ended March 31, 2011.
Net sales by industry markets for the three month period ended March 31, 2011 and 2010 are as follows:
| Three Months Ended March 31 | |
|---|---|
| 2011 2010% | |
| (in thousands) | $$ Change |
| Aerospace and Defense | 4,410 4,628 (5) |
| Medical | 8,009 5,730 40 |
| Industrial | 16,579 11,383 46 |
| Total Sales | 28,998 21,741 33 |
Net sales to our Aerospace and Defense customers for the three months ended March 31, 2011 was slightly lower than the three months ended March 31, 2010. The increase in net sales of $2.3 million to our Medical customers was due to the Milaca and Mankato acquisitions which added $1.5 million and $0.8 million respectively. The Mankato acquisition also impacted the Industrial customers by $3.2 million, while an additional $2.0 million increase in net sales was generated by our core industrial accounts.
Backlog:
Our 90-day order backlog as of March 31, 2011 was approximately $20.0 million, compared to approximately $18.5 million at the beginning of the quarter and $19.0 million at March 31, 2010. Backlog by industry market is shown below.
(in thousands)
| Backlog as of the Quarter Ended March 31 2011 | December 31% 2010 | Change | |
|---|---|---|---|
| Aerospace and Defense | $2,796 | $4,453 | (37) |
| Medical | 5,325 | 4,216 | 26 |
| Industrial | 11,895 | 9,813 | 21 |
| Total Backlog | $20,016 | $18,482 | 8 |
The lower 90 day Aerospace and Defense backlog is attributed to Defense budget funding delays and contractor project delays in the first quarter. The 90 day Medical backlog increased $1.1 million due primarily to our Milaca acquisition in May 2010. The 90 day Industrial backlog increased $2.1 million, with the Mankato acquisition accounting for substantially all of the increase.
Gross Profit:
Gross profit percentage for the three months ended March 31, 2011 and 2010 was 11.0% and 12.1% of net sales, respectively. Our gross profit percentage decreased due to the reinstatement of wages, incentives and benefits that had been suspended in the first six months of 2010, and absorbing the cost of integrating our acquisitions.
Selling Expense:
We had selling expenses of $0.9 million or 3.2% of net sales and 0.8 million or 3.5% of net sales for the three months ended March 31, 2011 and 2010, respectively. Selling expense as a percent of sales remains lower than historical levels. We anticipate increased investment in selling and business development activities to support the increased revenue levels and growth through acquisitions.
General and Administrative Expense:
Our general and administrative expenses were $2.0 million or 6.8% of net sales and $1.6 million or 7.2% of net sales for the three months ended March 31, 2011 and 2010, respectively. The increase in general and administrative dollars spent in 2011 is attributed to the re-instatement of wages and benefits to employees as we continue to recover from the 2009 economic downturn. It remains a management objective to continue to leverage our existing general and administrative resources as the company grows.
Other Income (Expense):
Other income for the three months ended March 31, 2011 was $0.7 million while other expense for the three months ended March 31, 2010 was $0.2 million. In the three months ended March 31, 2011 we recognized a bargain purchase gain of $0.8 million from the Mankato acquisition and experienced favorable interest expense and exchange rate fluctuations.
Income Taxes:
Income tax expense for the three months ended March 31, 2011 was $313,000 compared to income tax expense of $60,000 for the three months ended March 31, 2010 or approximately 33% and 39%, respectively. The annual effective tax rate for 2011 is expected to be approximately 33% compared to 36% for 2010. The decrease in rate from 2010 principally relates to the federal R&D credit that was not included in the prior year provision as it was not extended until the fourth quarter of 2010.
Liquidity and Capital Resources:
We have satisfied our liquidity needs over the past several years through revenue generated from operations and an operating line of credit through WFB. Both the line of credit and real estate term note are subject to fluctuations in the LIBOR rates. The line of credit and real estate term note with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets. On March 31, 2011, we had an outstanding balance of $9.7 million under the line of credit and unused availability of $2.6 million supported by our borrowing base. We believe our financing arrangements and cash flows provided by operations will be sufficient to satisfy our future working capital needs.
Our working capital of $12.1 million as of March 31, 2011 decreased from $13.1 million at December 31, 2010 mainly due to increased line of credit and current maturities of long term debt of $5.4 million, partially offset by increased inventories of $4.4 million.
Net cash used in operating activities for the three months ended March 31, 2011 was $3.9 million. The cash flow used in operations for the three months ended March 31, 2011 is the result of net income of $0.6 million, adjusted for increased inventories of $4.4 million and increased accounts receivable of $0.2 million. $2.8 million of the inventory increase was related to the Mankato acquisition (see Note 8).
Net cash used in investing activities of $1.3 million for the three months ended March 31, 2011 is comprised of $0.2 million in property and equipment purchases to support the business and $1.0 million for the Mankato operation acquisition (see Note 8).
Net cash provided by financing activities for the three months ended March 31, 2011 was $5.2 million, mainly due to the increase in borrowing on the line of credit and notes payable of $5.5 million, partially offset by debt payments of $0.3 million.
Critical Accounting Policies and Estimates
Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2010. There have been no significant changes in these critical accounting policies since December 31, 2010. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.
Forward-Looking Statements:
Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:
- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- General economic, financial and business conditions that could affect our financial condition and results of operations;
- Successful integration of recent acquisitions
The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.
Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2010.
Controls and procedures
As filed, 1,429 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures:
In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Executive Vice President and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the date of such evaluation in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting:
There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Source: SEC EDGAR, the filing index for accession 0001104659-11-028769. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.